Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMA1-C1/Alhydrogel + CPG 7909 vaccine for malaria
NCT00984763Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Countries
- 1
01
Overview
A Phase 2 trial of AMA1-C1/Alhydrogel in malaria, sponsored by University of Oxford. Started Jan 2010; status: completed.
02
Drugs
AMA1-C1/Alhydrogel
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00984763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984763.